Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Imeglimin hydrochloride

Catalog No. T7486Cas No. 775351-61-6
Alias EMD 387008 hydrochloride

Imeglimin hydrochloride (EMD 387008 hydrochloride) is an oral hypoglycemic agent. Imeglimin improves insulin sensitivity, inhibits the production of reactive oxygen species, increases mitochondrial DNA, and improves mitochondrial function.

Imeglimin hydrochloride

Imeglimin hydrochloride

Purity: 100%
Catalog No. T7486Alias EMD 387008 hydrochlorideCas No. 775351-61-6
Imeglimin hydrochloride (EMD 387008 hydrochloride) is an oral hypoglycemic agent. Imeglimin improves insulin sensitivity, inhibits the production of reactive oxygen species, increases mitochondrial DNA, and improves mitochondrial function.
Pack SizePriceAvailabilityQuantity
1 mg$34In Stock
2 mg$48In Stock
5 mg$79In Stock
10 mg$126In Stock
25 mg$229In Stock
50 mg$383In Stock
100 mg$578In Stock
500 mg$1,220In Stock
1 mL x 10 mM (in DMSO)$217In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Imeglimin hydrochloride"

Select Batch
Purity:100%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Imeglimin hydrochloride (EMD 387008 hydrochloride) is an oral hypoglycemic agent. Imeglimin improves insulin sensitivity, inhibits the production of reactive oxygen species, increases mitochondrial DNA, and improves mitochondrial function.
In vitro
METHODS: HMEC-1 cells were cultured in complete MCDB medium with indicated concentrations of glucose for 48 h in the absence or presence of 1 μM CsA, 250 μM N-acetylcysteine ​​(NAC), or 100 μM Imeglimin hydrochloride (EMD 387008 hydrochloride). Cytotoxicity was assessed by staining cells with Alexa Fluor-conjugated Annexin V and PI.
RESULTS Imeglimin hydrochloride prevented hyperglycemia-induced endothelial cell death. [1]
METHODS: HepG2 cells were treated with 1, 3, or 10 mM Imeglimin hydrochloride for 3 h and the resulting changes in basal oxygen consumption rate (OCR) and ATP production were observed.
RESULTS Imeglimin hydrochloride inhibited basal OCR and ATP production as well as maximal mitochondrial respiration in a concentration-dependent manner. [2]
In vivo
METHODS: Male C57BL/6J OlaHsd mice received imeglimin hydrochloride (EMD 387008 hydrochloride) (200 mg/kg b.i.d) by oral gavage during the last 6 weeks of HFHSD feeding to observe the antidiabetic effects of imeglimin.
RESULTS Imeglimin hydrochloride significantly reduced blood glucose and restored normal glucose tolerance. [3]
METHODS: C57BL/6J mice were maintained on a normal diet and a 12-h light/12-h dark cycle. At 8 weeks of age, male mice were deprived of food overnight, allowed to refeed for 5 h, and then injected intravenously with 250 mg/kg of imeglimin hydrochloride. Blood samples were collected from the tail vein 1 h after injection and blood glucose levels were measured using a glucometer.
RESULTS Imeglimin hydrochloride significantly reduced blood glucose, while plasma insulin levels were not affected by imeglimin. [3]
AliasEMD 387008 hydrochloride
Chemical Properties
Molecular Weight191.66
FormulaC6H14ClN5
Cas No.775351-61-6
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 55 mg/mL (286.97 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM5.2176 mL26.0879 mL52.1757 mL260.8786 mL
5 mM1.0435 mL5.2176 mL10.4351 mL52.1757 mL
10 mM0.5218 mL2.6088 mL5.2176 mL26.0879 mL
20 mM0.2609 mL1.3044 mL2.6088 mL13.0439 mL
50 mM0.1044 mL0.5218 mL1.0435 mL5.2176 mL
100 mM0.0522 mL0.2609 mL0.5218 mL2.6088 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Imeglimin hydrochloride | purchase Imeglimin hydrochloride | Imeglimin hydrochloride cost | order Imeglimin hydrochloride | Imeglimin hydrochloride chemical structure | Imeglimin hydrochloride in vivo | Imeglimin hydrochloride in vitro | Imeglimin hydrochloride formula | Imeglimin hydrochloride molecular weight